Search research articles
Contact Us
Filters
Showing results (441-450 of 493) with videos related to
Page
of 50
Sort By:
Cancer Medicine
|
November 2, 2025
Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes
Heather Derry-Vick, Neil J Shah, Jaeil Ahn, et al.
NPJ Precision Oncology
|
November 14, 2023
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
Gino K In, Jennifer R Ribeiro, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
Jean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
European Urology
|
March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Thomas Powles, Michael B Atkins, Bernard Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2020
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
T K Choueiri, R J Motzer, B I Rini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)
Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2014
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab
Suzanne L Topalian, Mario Sznol, David F McDermott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2026
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
T K Choueiri, L Albigès, D F McDermott, et al.
Annals of Surgical Oncology
|
February 18, 2014
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients
Charles M Balch, John F Thompson, Jeffrey E Gershenwald, et al.
Lancet (London, England)
|
March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B Haas, Judith Manola, Robert G Uzzo, et al.
Page
of 50
Search research articles
Search
Showing results (441-450 of 493) with videos related to
Sort By:
Page
of 50
Cancer Medicine
|
November 2, 2025
Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes
Heather Derry-Vick, Neil J Shah, Jaeil Ahn, et al.
NPJ Precision Oncology
|
November 14, 2023
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
Gino K In, Jennifer R Ribeiro, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
Jean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
European Urology
|
March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Thomas Powles, Michael B Atkins, Bernard Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2020
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
T K Choueiri, R J Motzer, B I Rini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)
Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2014
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab
Suzanne L Topalian, Mario Sznol, David F McDermott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2026
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
T K Choueiri, L Albigès, D F McDermott, et al.
Annals of Surgical Oncology
|
February 18, 2014
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients
Charles M Balch, John F Thompson, Jeffrey E Gershenwald, et al.
Lancet (London, England)
|
March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B Haas, Judith Manola, Robert G Uzzo, et al.
Page
of 50